WeVote
Log In

Bill

Bill

B 101-38

AN ACT TO ADD A NEW § 26203 (f) TO ARTICLE 2, CHAPTER 26, TITLE 11 GUAM CODE ANNOTATED, RELATIVE TO EXPANDING THE BUSINESS PRIVILEGE TAX EXEMPTIONS LIST TO INCLUDE PRESCRIPTION DRUGS.

38th Guam Legislature

Guam bill exempts prescription drugs from business privilege tax, potentially lowering medication costs but reducing government revenue without specified offsets.

0
WeVote Research Nonpartisan
Bill Summary · B 101-38

Legislative bill overview

This bill amends Guam's tax code to add prescription drugs to the list of business activities exempt from the business privilege tax. Currently, certain essential goods and services receive tax exemptions, and this legislation would extend that benefit to pharmaceutical products sold by licensed pharmacies.

Why is this important

Prescription drug costs significantly impact household budgets and healthcare accessibility, particularly in island territories where supply chain costs are higher. A tax exemption could lower medication prices for consumers, though it would reduce government revenue that funds public services and infrastructure.

Potential points of contention

  • Revenue impact: Guam's government budget is constrained; losing tax revenue from pharmacy sales requires offsetting cuts or new revenue sources elsewhere
  • Definition scope: The bill's language may need clarification on which drugs qualify (all prescription medications, controlled substances, over-the-counter vs. prescription-only items)
  • Equity concerns: Tax exemptions benefit all purchasers equally regardless of income, whereas means-tested assistance programs could target help to lower-income residents more efficiently
  • Economic effects on pharmacies: Unclear whether savings would be passed to consumers or retained as increased margins by pharmacy owners

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.